SPY334.19+5.46 1.66%
DIA275.90+4.20 1.55%
IXIC11,117.53+203.96 1.87%

Alkermes shares are trading lower. The company announced the FDA Advisory Committee will review its New Drug Application for ALKS 3831. The review is tentatively scheduled for October 9th.

Benzinga · 08/21/2020 16:24